We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.02B
1-Year Est. Return
53.92%
This Fund
S&P 500
This Quarter
Est. Return
-15.33%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$1.87B
AUM Growth
-$449M
(-19%)
Cap. Flow
-$58.7M
Cap. Flow
% of AUM
-3.14%
Top 10 Holdings %
Top 10 Hldgs %
33.16%
Holding
358
New
37
Increased
55
Reduced
86
Closed
52
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$48.3M |
| 2 |
UnitedHealth
UNH
|
+$32.7M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$19.2M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17.8M |
| 5 |
CME Group
CME
|
+$15.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$39.5M |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$26.5M |
| 3 |
Freeport-McMoran
FCX
|
+$17.7M |
| 4 |
MRO
Marathon Oil Corporation
MRO
|
+$17.1M |
| 5 |
Regal Rexnord
RRX
|
+$12.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.33% |
| 2 | Healthcare | 15.76% |
| 3 | Consumer Discretionary | 13.02% |
| 4 | Financials | 12.7% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$2.98T
| $101M | 5.41% |
393,620
-1,880
| -0.5% | -$510K |
|
2
Apple
AAPL
$5.05T
| $88.6M | 4.74% |
647,910
+1,240
| +0.2% | +$188K |
|
3
Alphabet (Google) Class A
GOOGL
$4.18T
| $72.5M | 3.88% |
665,340
+55,720
| +9% | +$6.56M |
|
4
Mastercard
MA
$500B
| $64.5M | 3.45% |
204,457
+790
| +0.4% | +$272K |
|
5
Ulta Beauty
ULTA
$22.1B
| $52.4M | 2.8% |
135,915
-19,510
| -13% | -$7.75M |
|
6
Eli Lilly
LLY
$1.09T
| $50.9M | 2.72% |
156,945
-9,650
| -6% | -$2.9M |
|
7
Visa
V
$704B
| $49.1M | 2.63% |
249,450
+760
| +0.3% | +$157K |
|
|
8
State Street SPDR S&P Biotech ETF
XBI
$10.2B
| $47.8M | 2.56% |
+643,890
| New | +$48.3M |
|
|
9
State Street SPDR S&P 500 ETF Trust
SPY
$785B
| $47.1M | 2.52% |
124,800
+43,470
| +53% | +$17.8M |
|
|
SCHW
10
Charles Schwab
SCHW
$184B
| $45.7M | 2.45% |
723,515
+1,640
| +0.2% | +$113K |
|
11
Nike
NKE
$64.8B
| $41.7M | 2.23% |
408,005
+10
| +0% | +$1.18K |
|
12
NVIDIA
NVDA
$4.75T
| $41.6M | 2.23% |
2,744,180
+10,600
| +0.4% | +$200K |
|
13
Lam Research
LRCX
$334B
| $41.4M | 2.22% |
971,600
+46,300
| +5% | +$2.2M |
|
14
Edwards Lifesciences
EW
$49.4B
| $39.3M | 2.1% |
412,965
+46,150
| +13% | +$4.78M |
|
15
Union Pacific
UNP
$174B
| $36.6M | 1.96% |
171,395
+13,250
| +8% | +$3.01M |
|
|
16
UnitedHealth
UNH
$386B
| $33.4M | 1.79% |
+65,050
| New | +$32.7M |
|
17
Tesla
TSLA
$1.21T
| $31.2M | 1.67% |
139,074
-4,680
| -3% | -$1.28M |
|
18
lululemon athletica
LULU
$13.7B
| $30.7M | 1.65% |
112,776
+40,543
| +56% | +$13M |
|
19
Las Vegas Sands
LVS
$32.3B
| $27.1M | 1.45% |
805,369
+141,260
| +21% | +$4.89M |
|
|
SWN
20
DELISTED
Southwestern Energy Company
SWN
| $22.8M | 1.22% |
3,649,760
+1,799,970
| +97% | +$13.9M |
|
21
ASML
ASML
$619B
| $22.3M | 1.19% |
46,780
+3,120
| +7% | +$1.74M |
|
22
Estee Lauder
EL
$31B
| $21.6M | 1.15% |
84,690
+1,390
| +2% | +$353K |
|
23
Adobe
ADBE
$105B
| $21.1M | 1.13% |
57,715
+210
| +0.4% | +$85.5K |
|
24
Amazon
AMZN
$2.5T
| $18M | 0.96% |
169,580
-88,400
| -34% | -$11.1M |
|
|
25
Invesco QQQ Trust
QQQ
$447B
| $17.3M | 0.93% |
+61,900
| New | +$19.2M |
|
Similar funds
MCM
JIC
CFM
SM
TAM
KIA
BGDI
Castleark Management's Q2 2022 Portfolio in Review
As of Q2 2022, Castleark Management held 358 positions worth $1.87B, down 19% from $2.32B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Castleark Management withdrew a net $58.7M in Q2 2022, closing 52 positions and reducing 86 holdings. Its most notable exit was State Street Materials Select Sector SPDR ETF, an estimated $26.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Castleark Management opened a new position in State Street SPDR S&P Biotech ETF worth $47.8M.
- Castleark Management's largest Q2 2022 buy was State Street SPDR S&P Biotech ETF: 643,890 shares worth $47.8M.
- Castleark Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $17.8M increase.
- Castleark Management's biggest Q2 2022 reduction was Microchip Technology, cutting an estimated $39.5M.
- Castleark Management fully exited State Street Materials Select Sector SPDR ETF in Q2 2022, selling an estimated $26.5M.
- Castleark Management's ten largest holdings make up 33% of its $1.87B portfolio in Q2 2022.
- Castleark Management opened 37 new positions and closed 52 in Q2 2022.
- Castleark Management's portfolio value fell 19% quarter-over-quarter to $1.87B.
Based on Castleark Management's 13F filing for Q2 2022, filed 16 Aug 2022.